Primary and secondary prevention of Type 1 diabetes
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Since type 1 diabetes is an immunologically mediated disease, immune intervention should alter the natural history of the disease. This article reviews prevention studies undertaken either prior to any evidence of autoimmunity (primary prevention) or after the development of islet autoantibodies (secondary prevention). Most immune intervention studies have been conducted in recent‐onset type 1 diabetes (tertiary prevention), and these are not reviewed herein. The goal of primary and secondary intervention is to arrest the immune process and thus prevent or delay clinical disease. Primary prevention studies have been conducted in infants with high genetic risk. Interventions tested include several dietary manipulations, including infant formulas free of either cow's milk or of bovine insulin, infant formula supplemented with the omega‐3‐fatty acid docosahexaenoic acid, delayed introduction of gluten‐containing foods, and vitamin D supplementation. Secondary prevention studies have been conducted in both children and adults with diabetes autoantibodies. Interventions tested include nicotinamide, insulin injections, oral insulin, nasal insulin, glutamic acid decarboxylase, and cyclosporine. Underway are secondary prevention studies with teplizumab and with abatacept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Norris, J. M. (2003) · JAMA · doi:10.1001/jama.290.13.1713 · Cited by 515
Näntö-Salonen, K., Kupila, A., Simell, S., Siljander, H., Salonsaari, T., Hekkala, A., Korhonen, S., Erkkola, R., Sipilä, J. I., Haavisto, L., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61309-4 · Cited by 382
Dietary intervention in infancy and later signs of beta-cell autoimmunity
Knip, M., Virtanen, S. M., Seppä, K., Ilonen, J., Savilahti, E., Vaarala, O., Reunanen, A., Teramo, K., Hämäläinen, A.-M., Paronen, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004809 · Cited by 281
Infant feeding and the risk of type 1 diabetes
Knip, M., Virtanen, S. M., & Åkerblom, H. K. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28701c · Cited by 156
Vaarala, O., Ilonen, J., Ruohtula, T., Pesola, J., Virtanen, S. M., Härkönen, T., Koski, M., Kallioinen, H., Tossavainen, O., Poussa, T., et al. (2012) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.1559 · Cited by 127
Update on Worldwide Efforts to Prevent Type 1 Diabetes
Skyler, J. S., & for the Type 1 Diabetes TrialNet Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.055 · Cited by 66
Self-citation
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
Early prediction of autoimmune (type 1) diabetes.
Regnell, S. E., & Lernmark, Å. (2017) · Diabetologia · doi:10.1007/s00125-017-4308-1 · Cited by 195
“Large, prospective studies of environmental determinants of type 1 diabetes and efforts to translate their findings into preventative interventions are ongoing [62].”
BackgroundIdentification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes
McLaughlin, K. A., Richardson, C. C., Ravishankar, A., Brigatti, C., Liberati, D., Lampasona, V., Piemonti, L., Morgan, D., Feltbower, R. G., & Christie, M. R. (2016) · Diabetes · doi:10.2337/db15-1058 · Cited by 113
“Evidence from both animal studies and human trials (3,4) indicates that type 1 diabetes may be prevented in individuals at risk.”
ResultHope vs hype: where are we in type 1 diabetes?
Skyler, J. S. (2018) · Diabetologia · doi:10.1007/s00125-017-4530-x · Cited by 51
“However, to date, none of several tested interventions has been successful in preventing type 1 diabetes in human beings [48, 49].”
BackgroundSelf-citation
Metadata
- Authors
- Skyler, J. S.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2013-01-21
- Volume
- 30
- Issue
- 2
- Pages
- 161-169
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2038585732
- Cited by
- 93
- References
- 10
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary and secondary prevention of Type 1 diabetes. https://app.cochat.ai/papers/10.1111/dme.12100
- The paper
- Skyler, J. S. (2013). Primary and secondary prevention of Type 1 diabetes. Diabetic Medicine. https://doi.org/10.1111/dme.12100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.